Searched for
OSTEOARTHRITIS DATA
AI treatment for weight-loss: Artificial Intelligence tools help researchers analyze 1,300 medical conditions, right medicinesResearchers analyzed 14 million doctors’ notes and 15 million clinical data entries from more than 135,000 patients with and without diabet...- Sun Pharma-Moebius Medical anti-osteoarthritis pain drug gets USFDA fast track statusSun Pharma and Moebius Medical have received fast track designation from the USFDA for their non-opioid therapy MM-II, aimed at treating os...
- Sun Pharma-Moebius Medical anti-osteoarthritis injection shows sustained pain relief in clinical trialsSun Pharma and Moebius Medical announced that their intra-articular injection MM-II showed greater pain relief than placebo for up to 26 we...
- What other health conditions might weight-loss drugs treat?New data suggests that semaglutide may also cut the risk of stroke or heart attack, and may delay the progression of kidney disease in diab...
- Around 1 bn people globally will live with osteoarthritis by 2050, says Lancet studyA recent study published in The Lancet Rheumatology journal predicts that nearly one billion people worldwide will be living with osteoarth...
- One billion people globally to have osteoarthritis by 2050: Lancet StudyBy 2050, nearly one billion people globally are projected to be living with osteoarthritis, according to a study published in The Lancet Rh...
- Zydus Lifesciences gets USFDA nod for generic rheumatoid arthritis treatment drugZydus Lifesciences has gained the US Food and Drug Administration's (FDA) approval to produce and market its Indomethacin suppositories. Th...
- IIT-Guwahati develops framework to assess Knee Osteoarthritis severityResearchers from the Indian Institute of Technology Guwahati have developed an artificial intelligence-based model named OsteoHRNet, which ...
- Lupin launches generic joint pain drug in US marketThe company's product -- Diclofenac Sodium Topical Solution 2 per cent -- is the generic version of Horizon Pharma Therapeutics Pennsaid, L...
- Scientists develop model for better diagnosis, treatment of osteoarthritisThe paper builds on another recent study the RIT-Cornell team published in Soft Matter that looked at how cartilage's properties resisted f...
- Lupin launches generic drug in the US marketThe Mumbai-based drug firm's product is the generic equivalent of Zyla Life Sciences' Vivlodex Capsules (5 mg and 10 mg). The capsules are ...
- Trending stocks: Lupin shares rise over 1%A total of 44,197 shares changed hands on the counter till 10:38AM (IST).
- Abbott jumps on to digital health service bandwagonAbbott will also look at partnering with e-pharmacies, diagnostic chains and physicians to provide patients with discounts.
- Clinical trials by pharmaceutical companies still gasping for transparencyData available in the public domain shows Malpani Hospital has conducted over 40 clinical trials for osteoarthritis and rheumatoid arthriti...
- Sun Pharma, Moebius Medical to develop osteoarthritis pain productMM-II is an intra-articular bio lubricant injection which is being developed to provide symptomatic relief of mild-to-moderate osteoarthrit...
- Lupin gets USFDA nod for Diclofenac capsules' generic versionLupin has 139 product filings pending approval with the USFDA. Cumulative filings with the USFDA now stand at 341 with the company having r...
- Lupin gets USFDA nod for arthritis drugThe company has also received tentative approvals for its product in strengths of 100 mg, 200 mg and 400 mg from the FDA.
- Lupin gets USFDA approval for arthritis tabletsLupin Pharmaceuticals Inc has been granted final approval by US Food and Drug Administration for Nabumetone tablets in strengths of 500mg a...
- Glenmark inks $325-mn licensing deal with SanofiGlenmark Pharmaceuticals licensed its chronic pain molecule to Sanofi Aventis for an upfront payment of $20 million (approximately Rs 89 cr...
- Philippines orders Novartis to pull anti-arthritis drugPhilippine health regulators on Friday ordered Swiss pharmaceutical giant Novartis to pull the painkiller Lumiracoxib from the market amid ...
Load More
